No Data
With Johnson & Johnson (NYSE:JNJ) It Looks Like You'll Get What You Pay For
Express News | Johnson & Johnson Submits Applications in the U.S. and EU Seeking Approval of Darzalex Faspro® / Darzalex® as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Express News | shanghai Municipal Medical Insurance Bureau organizes centralized procurement of pharmaceuticals and high-value consumables exceeding 2 billion yuan
J&J Wins Approval of Varipulse Atrial Fibrillation Device
Industry Comparison: Evaluating Johnson & Johnson Against Competitors In Pharmaceuticals Industry
Band-Aid, Tylenol Parent's Sales Miss the Mark Amid Weakness in Skin Health
No Data
No Data
